![](https://investorshub.advfn.com/uicon/33511.png?cb=1696427377)
Sunday, October 20, 2013 8:23:39 PM
look, AMBS also owns an inventory of 88 cell lines referred to as PhenoGuard Cell Lines in AMBS's IP portfolio, as well as other valuable assets that don't necessarily constitute product sales. What do you think AMBS's IP portfolio is worth? If I am to interpret Gerald's dialogue correctly, he was speaking monolithically - AMBS as a whole entity...
"We think this represents a $300-Mil. opportunity and a potential acquisition"
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM